Literature DB >> 12795338

The neurodevelopmental hypothesis of schizophrenia: a review of recent developments.

John J McGrath1, François P Féron, Thomas H J Burne, Alan Mackay-Sim, Darryl W Eyles.   

Abstract

The neurodevelopmental hypothesis (NDH) of schizophrenia suggests that a disruption of brain development during early life underlies the later emergence of psychosis during adulthood. The aim of this review is to chart the challenges and subsequent refinements to this hypothesis, with particular reference to the static versus progressive nature of the putative neurobiological processes underlying the NDH. A non-systematic literature review was undertaken, with an emphasis on major review papers relevant to the NDH. Weaknesses in the explanatory power of the NDH have led to a new generation of more refined hypotheses in recent years. In particular, recent versions of the hypothesis have incorporated evidence from structural neuroimaging which suggests changes in brain volumes after the onset of schizophrenia. More detailed models that incorporate progressive neurobiological processes have replaced early versions of the NDH, which were based on a 'static encephalopathy'. In addition, recent models have suggested that two or more 'hits' are required over the lifespan rather than only one early-life event. Animal models are providing important insights into the sequelae of disturbed early brain development. The NDH has provided great impetus to the schizophrenia research community. Recent versions of the hypothesis have encouraged more focused and testable hypotheses.

Entities:  

Mesh:

Year:  2003        PMID: 12795338     DOI: 10.1080/07853890310010005

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  38 in total

Review 1.  Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions.

Authors:  Richard S Jope; Myoung-Sun Roh
Journal:  Curr Drug Targets       Date:  2006-11       Impact factor: 3.465

2.  Common variants in the MKL1 gene confer risk of schizophrenia.

Authors:  Xiong-Jian Luo; Liang Huang; Edwin J van den Oord; Karolina A Aberg; Lin Gan; Zhongming Zhao; Yong-Gang Yao
Journal:  Schizophr Bull       Date:  2014-11-07       Impact factor: 9.306

3.  Zinc Supplementation During Pregnancy Alleviates Lipopolysaccharide-Induced Glial Activation and Inflammatory Markers Expression in a Rat Model of Maternal Immune Activation.

Authors:  Ronak Mousaviyan; Nahid Davoodian; Faezeh Alizadeh; Maryam Ghasemi-Kasman; Seyed Abdollah Mousavi; Fatemeh Shaerzadeh; Haniyeh Kazemi
Journal:  Biol Trace Elem Res       Date:  2021-01-05       Impact factor: 3.738

4.  HLA-B maternal-fetal genotype matching increases risk of schizophrenia.

Authors:  Christina G S Palmer; Hsin-Ju Hsieh; Elaine F Reed; Jouko Lonnqvist; Leena Peltonen; J Arthur Woodward; Janet S Sinsheimer
Journal:  Am J Hum Genet       Date:  2006-08-15       Impact factor: 11.025

5.  Minor physical anomalies in schizophrenia: a meta-analysis.

Authors:  Seth M Weinberg; Elizabeth A Jenkins; Mary L Marazita; Brion S Maher
Journal:  Schizophr Res       Date:  2006-10-31       Impact factor: 4.939

Review 6.  Evidence for maternal-fetal genotype incompatibility as a risk factor for schizophrenia.

Authors:  Christina G S Palmer
Journal:  J Biomed Biotechnol       Date:  2010-04-06

7.  Frontonasal dysmorphology in bipolar disorder by 3D laser surface imaging and geometric morphometrics: comparisons with schizophrenia.

Authors:  Robin J Hennessy; Patrizia A Baldwin; David J Browne; Anthony Kinsella; John L Waddington
Journal:  Schizophr Res       Date:  2010-05-31       Impact factor: 4.939

8.  N-acetyl cysteine reverses bio-behavioural changes induced by prenatal inflammation, adolescent methamphetamine exposure and combined challenges.

Authors:  Twanette Swanepoel; Marisa Möller; Brian Herbert Harvey
Journal:  Psychopharmacology (Berl)       Date:  2017-11-08       Impact factor: 4.530

Review 9.  Diabetes mellitus during pregnancy and increased risk of schizophrenia in offspring: a review of the evidence and putative mechanisms.

Authors:  Ryan J Van Lieshout; Lakshmi P Voruganti
Journal:  J Psychiatry Neurosci       Date:  2008-09       Impact factor: 6.186

10.  Rare variants in the neurotrophin signaling pathway implicated in schizophrenia risk.

Authors:  Thorsten M Kranz; Ray R Goetz; Julie Walsh-Messinger; Deborah Goetz; Daniel Antonius; Igor Dolgalev; Adriana Heguy; Marco Seandel; Dolores Malaspina; Moses V Chao
Journal:  Schizophr Res       Date:  2015-07-26       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.